Abeona Therapeutics, Inc. <ABEO.O>: Oppenheimer cuts target price to $21 from $22
ABEO•Related News
Amber International’s Zhang Steve Sheng, co-CFO, files initial beneficial ownership statement
AMBR•
Oconee Federal Financial Corp. Announces Annual Financial Results
OFED•
Zoomcar Delivers Record Contribution Profit Of $1.65 Million Margin Per Booking Rises To 70% Or $18.75
ZCAR•
MicroVision Announces Pricing Of $17.0 Million Public Offering
MVIS•
Copper drifts lower on profit taking, economic uncertainty
XLB•